NFATC3
Nuclear factor of activated T-cells, cytoplasmic 3
Also known as: NFAC3_HUMAN, NFAT4, NFATX
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q12968
- Gene
- NFATC3
- Ensembl
- ENSG00000072736
- Chromosome
- 16
- Canonical length
- 1075 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The product of this gene is a member of the nuclear factors of activated T cells DNA-binding transcription complex. This complex consists of at least two components: a preexisting cytosolic component that translocates to the nucleus upon T cell receptor (TCR) stimulation and an inducible nuclear component. Other members of this family participate to form this complex also. The product of this gene plays a role in the regulation of gene expression in T cells and immature thymocytes. Several transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
1075 residues, UniProt reviewed canonical sequence.
>Q12968|NFATC3
1 MTTANCGAHD ELDFKLVFGE DGAPAPPPPG SRPADLEPDD CASIYIFNVD PPPSTLTTPL
61 CLPHHGLPSH SSVLSPSFQL QSHKNYEGTC EIPESKYSPL GGPKPFECPS IQITSISPNC
121 HQELDAHEDD LQINDPEREF LERPSRDHLY LPLEPSYRES SLSPSPASSI SSRSWFSDAS
181 SCESLSHIYD DVDSELNEAA ARFTLGSPLT SPGGSPGGCP GEETWHQQYG LGHSLSPRQS
241 PCHSPRSSVT DENWLSPRPA SGPSSRPTSP CGKRRHSSAE VCYAGSLSPH HSPVPSPGHS
301 PRGSVTEDTW LNASVHGGSG LGPAVFPFQY CVETDIPLKT RKTSEDQAAI LPGKLELCSD
361 DQGSLSPARE TSIDDGLGSQ YPLKKDSCGD QFLSVPSPFT WSKPKPGHTP IFRTSSLPPL
421 DWPLPAHFGQ CELKIEVQPK THHRAHYETE GSRGAVKAST GGHPVVKLLG YNEKPINLQM
481 FIGTADDRYL RPHAFYQVHR ITGKTVATAS QEIIIASTKV LEIPLLPENN MSASIDCAGI
541 LKLRNSDIEL RKGETDIGRK NTRVRLVFRV HIPQPSGKVL SLQIASIPVE CSQRSAQELP
601 HIEKYSINSC SVNGGHEMVV TGSNFLPESK IIFLEKGQDG RPQWEVEGKI IREKCQGAHI
661 VLEVPPYHNP AVTAAVQVHF YLCNGKRKKS QSQRFTYTPV LMKQEHREEI DLSSVPSLPV
721 PHPAQTQRPS SDSGCSHDSV LSGQRSLICS IPQTYASMVT SSHLPQLQCR DESVSKEQHM
781 IPSPIVHQPF QVTPTPPVGS SYQPMQTNVV YNGPTCLPIN AASSQEFDSV LFQQDATLSG
841 LVNLGCQPLS SIPFHSSNSG STGHLLAHTP HSVHTLPHLQ SMGYHCSNTG QRSLSSPVAD
901 QITGQPSSQL QPITYGPSHS GSATTASPAA SHPLASSPLS GPPSPQLQPM PYQSPSSGTA
961 SSPSPATRMH SGQHSTQAQS TGQGGLSAPS SLICHSLCDP ASFPPDGATV SIKPEPEDRE
1021 PNFATIGLQD ITLDDVNEII GRDMSQISVS QGAGVSRQAP LPSPESLDLG RSDGLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NFATC3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.6
- Highest tissue expression
- 95 nTPM
Expression across tissuesHPA
Tissue
- thymus: 95 nTPM
- skeletal muscle: 27 nTPM
- testis: 25 nTPM
- bone marrow: 22 nTPM
- lymph node: 22 nTPM
- parathyroid gland: 22 nTPM
Single-cell type
- myonuclei: 360 nCPM
- podocytes: 354 nCPM
- nk-cells: 239 nCPM
- sertoli cells: 219 nCPM
- neutrophil progenitors: 217 nCPM
- proximal tubule cells: 213 nCPM
Immune cell
- gdT-cell: 21 nTPM
- memory CD8 T-cell: 21 nTPM
- NK-cell: 21 nTPM
- MAIT T-cell: 20 nTPM
- naive CD8 T-cell: 19 nTPM
- basophil: 17 nTPM
Brain region
- cerebellum: 26 nTPM
- white matter: 25 nTPM
- medulla oblongata: 23 nTPM
- choroid plexus: 23 nTPM
- basal ganglia: 22 nTPM
- midbrain: 21 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.49
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcineurin-NFAT signaling cascade
- DN4 thymocyte differentiation
- inflammatory response
- negative regulation of miRNA transcription
- negative regulation of vascular associated smooth muscle cell differentiation
- positive regulation of artery morphogenesis
- positive regulation of nitric oxide biosynthetic process
- positive regulation of transcription by RNA polymerase II
- positive thymic T cell selection
- regulation of transcription by RNA polymerase II
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- IPT domain
- Nuclear factor of activated T cells (NFAT)
- p53-like transcription factor, DNA-binding domain superfamily
- Rel homology domain, DNA-binding domain
- Immunoglobulin-like fold
- Immunoglobulin E-set
- Rel homology dimerisation domain
- Rel homology domain (RHD), DNA-binding domain superfamily
- Rel homology DNA-binding domain
- Rel homology dimerisation domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NFATC3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NFATC3 as an antibody target. Whether an autoantibody or antibody against NFATC3 could matter depends on whether native NFATC3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NFATC3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NFATC3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...